Literature DB >> 235288

The binding of hemoglobin to membranes of normal and sickle erythrocytes.

S Fischer, R L Nagel, R M Bookchin, E F Roth, I Tellez-Nagel.   

Abstract

The binding of hemoglobins A, S, and A2 to red cell membranes prepared by hypotonic lysis from normal blood and blood from persons with sickle cell anemia was quantified under a variety of conditions using hemoglobin labelled by alkylation with 14C-labelled Nitrogen Mustard. Membrane morphology was examined by electron microscopy. Normal membranes were found capable of binding native hemoglobin A and hemoglobin S in similar amounts when incubated at low hemoglobin: membrane ratios, but at high ratios hemoglobin saturation levels of the membranes increased progressively for hemoglobin A, hemoglobin S and hemoglobin A2, respectively, in order of increasing electropositivity. Binding was unaffected by variations in temperature (4-22 degrees C) and altered little by the presence of sulfhydryl reagents, but was inhibited at pH levels above 7.35; disrupted at high ionic strength; and dependent on the ionic composition of the media. These findings suggest that electrostatic, but not hydrophobic or sulfhydryl bonds are important in membrane binding of the hemoglobin under the conditions studied. An increased retention of hemoglobin in preparations of membranes from red cells of patients with sickle cell anemia (homozygote S) was attributable to the dense fraction of homozygote S red cells rich in irreversibly sickled cells, and the latter membranes had a smaller residual binding capacity for new hemoglobin. This suggests that in homozygote S cells which have become irreversibly sickled cells in vivo, there are membrane changes which involve alteration and/or blockade of hemoglobin binding sites. These findings support the notion that hemoglobin participates in the dynamic structure of the red cell membrane in a manner which differs in normal and pathological states.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235288     DOI: 10.1016/0005-2736(75)90357-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

Review 1.  Efficient Exploration of Membrane-Associated Phenomena at Atomic Resolution.

Authors:  Josh V Vermaas; Javier L Baylon; Mark J Arcario; Melanie P Muller; Zhe Wu; Taras V Pogorelov; Emad Tajkhorshid
Journal:  J Membr Biol       Date:  2015-05-22       Impact factor: 1.843

2.  The effect of magnesium on the hemolysis of calf and adult cattle erythrocytes.

Authors:  S Imre; J Plotkin; O W Thiele
Journal:  Blut       Date:  1978-10-13

Review 3.  Interaction of hemoglobin with band 3: a review.

Authors:  R K Kaul; H Köhler
Journal:  Klin Wochenschr       Date:  1983-09-01

4.  Association of hemoglobin C with erythrocyte ghosts.

Authors:  G H Reiss; H M Ranney; N Shaklai
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

5.  Interaction of sickle cell hemoglobin with erythrocyte membranes.

Authors:  N Shaklai; V S Sharma; H M Ranney
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  Effect of a 'sickling pulse' on calcium and potassium transport in sickle cell trait red cells.

Authors:  R M Bookchin; V L Lew
Journal:  J Physiol       Date:  1981-03       Impact factor: 5.182

7.  Cytosolic protein binding to band-3 protein inhibits endocytosis of isolated human erythrocyte membranes.

Authors:  K A Cordes; J M Salhany
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

8.  Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.

Authors:  J A Walder; R H Zaugg; R S Iwaoka; W G Watkin; I M Klotz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Denatured hemoglobin in sickle erythrocytes.

Authors:  T Asakura; K Minakata; K Adachi; M O Russell; E Schwartz
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

10.  Study of irreversibly sickled cells in an animal model.

Authors:  O Castro; J D Cochran
Journal:  J Natl Med Assoc       Date:  1978-01       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.